Literature DB >> 314442

The influence of clavulanic acid on the susceptibility to amoxycillin of beta-lactamase producing strains of H. influenzae using different inoculum sizes.

B Van Klingeren, M Dessens-Kroon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 314442     DOI： 10.1093/jac/5.3.322

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

Review 1.  Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

Review 2.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  In vitro and in vivo synergism between amoxicillin and clavulanic acid against ampicillin-resistant Haemophilus influenzae type b.

Authors:  R Yogev; C Melick; W J Kabat
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

4.  In vitro activities of aztreonam, imipenem, and amoxycillin-clavulanate against ampicillin-resistant Haemophilus influenzae.

Authors:  M Powell; J D Williams
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

5.  In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.

Authors:  B O Liljequist; L Gezelius
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

6.  A combination of amoxicillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxicillin-resistant haemophilus influenzae.

Authors:  H Beeuwkes; V H Rutgers
Journal:  Infection       Date:  1981       Impact factor: 3.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.